Changes In Clinical Trials Mechanism Inevitable, But NCI Says It will Heed Critics Of Proposals
In Brief: Cancer Control Month: Reagan Advises Americans To Stop Tobacco Use; Eat More Fiber, Less Fat
MAP Says It Will Continue Operating With Private Funds
NCI Says More Phase Trials Needed In Cancer Prevention, Nutrition
Kaiser Foundation Offers Community Health Grants
Counseling reduces Pain, Study Shows
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ









